Literature DB >> 21825896

Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.

Xin-ming Song1, Xiang Gao, Ming-zhe Li, Zhi-hui Chen, Shi-cai Chen, Pin-Jin Hu, Yu-long He, Wen-hua Zhan, Min-hu Chen.   

Abstract

BACKGROUND: The frequency of Crohn's disease in China is increasing, but few reports are available on clinical features, phenotypes according to the Montreal classification, or risk factors for surgery in mainland China.
OBJECTIVE: This study aimed to assess clinical presentation, phenotypes according to the Montreal classification, and potential risk factors for initial surgery in patients with Crohn's disease in southern China.
DESIGN: This was an observational study designed as a retrospective analysis of a historical cohort. SETTINGS: The study was conducted at a tertiary referral hospital, Guangzhou, China. PATIENTS: Medical records of 212 consecutive patients with Crohn's disease were reviewed; data from 205 patients who met inclusion criteria were analyzed. MAIN OUTCOME MEASURES: The value of age, location, and behavior of disease according to the Montreal system, smoking behavior, and other clinical variables as potential risk factors in predicting the requirement for initial surgery was assessed by use of Cox regression analysis.
RESULTS: A total of 205 patients were studied. Abdominal pain (181 patients, 88.3%) was the most common clinical presentation. At the time of diagnosis, age was between 17 and 40 years in 145 patients (70.7%). The Montreal classification of disease location was L3 (ileocolonic) in 114 patients (55.6%), disease behavior was classified as inflammatory in 133 patients (64.9%). During the course of their disease (median, 4 years; range, 1-21 years), 79 patients (38.5%) required bowel resection. Kaplan-Meier analysis showed that the overall cumulative rate of primary bowel surgery was 17.6% at 1 year after onset of symptoms, 20.3% at 2 years, 35.2% at 5 years, and 58.3% at 10 years. In our final Cox model, stricturing (HR, 3.67; 95% CI, 2.14-6.29; P < .001), penetrating behavior (HR, 4.60; 95% CI, 2.58-8.22; P < .001), and smoking habit (HR, 2.02; 95% CI, 1.15-3.53; P = .014) were significantly associated with an increased risk for bowel resection. LIMITATIONS: The study was limited by its retrospective nature.
CONCLUSIONS: In Chinese patients with Crohn's disease, abdominal pain is the most common clinical presentation, and the most common phenotypes are age 17 to 40 years at diagnosis, ileocolonic disease location, and inflammatory disease behavior. More than one-third of patients require surgery at a median of 4 years after onset of symptoms. Stricturing, penetrating disease, and smoking are associated with an increased risk of requiring bowel resection.

Entities:  

Mesh:

Year:  2011        PMID: 21825896     DOI: 10.1097/DCR.0b013e318222ddc3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  18 in total

1.  Risk factors for initial surgery in patients with Crohn's disease in Central China.

Authors:  Min Chen; Fengming Yi; Feng Zhou; Meifang Huang; Jin Li; Wenfeng Yan; Lixia Li; Bing Xia
Journal:  Surg Today       Date:  2014-12-20       Impact factor: 2.549

2.  Clinical Features and Prognosis of Crohn's Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients.

Authors:  Xiao-Wei Sun; Juan Wei; Zhao Yang; Xin-Xin Jin; Hai-Jun Wan; Bo-Si Yuan; Miao-Fang Yang; Jiong Liu; Fang-Yu Wang
Journal:  Dig Dis Sci       Date:  2019-05-11       Impact factor: 3.199

Review 3.  Crohn's Disease of the Esophagus, Duodenum, and Stomach.

Authors:  David M Schwartzberg; Stephen Brandstetter; Alexis L Grucela
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

4.  Features and perspectives of MR enterography for pediatric Crohn disease assessment.

Authors:  Noemi Maria Giovanna Ognibene; Massimo Basile; Marco Di Maurizio; Giuseppe Petrillo; Claudio De Filippi
Journal:  Radiol Med       Date:  2016-02-02       Impact factor: 3.469

5.  MR-enterography in Crohn's disease: what MRE mural parameters are associated to one-year therapeutic management outcome?

Authors:  Pier Paolo Mainenti; Fabiana Castiglione; Antonio Rispo; Ettore Laccetti; Salvatore Guarino; Valeria Romeo; Anna Testa; Leonardo Pace; Simone Maurea
Journal:  Br J Radiol       Date:  2020-11-13       Impact factor: 3.039

6.  The association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal Classification System.

Authors:  Abigail Basson; Rina Swart; Esme Jordaan; Mikateko Mazinu; Gillian Watermeyer
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

7.  Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults.

Authors:  Fumihito Hirai; Hiroshi Ishihara; Shinichirou Yada; Motohiro Esaki; Tomohisa Ohwan; Ryoichi Nozaki; Shinya Ashizuka; Haruhiko Inatsu; Hidehisa Ohi; Kunihiko Aoyagi; Yohei Mizuta; Takayuki Matsumoto; Toshiyuki Matsui
Journal:  Dig Dis Sci       Date:  2012-08-29       Impact factor: 3.199

8.  Characteristic phenotypes in Korean Crohn's disease patients who underwent intestinal surgery for the treatment.

Authors:  Seung Hyuk Baik; Kyu Joo Park; Kang Young Lee; Yong Beom Cho; Gyu-Seog Choi; Kil Yeon Lee; Sang Nam Yoon; Chang Sik Yu
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

9.  Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study.

Authors:  Chang Mo Moon; Sung-Ae Jung; Seong-Eun Kim; Hyun Joo Song; Yunho Jung; Byong Duk Ye; Jae Hee Cheon; You Sun Kim; Young-Ho Kim; Joo Sung Kim; Dong Soo Han
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

10.  Risk factors for postoperative recurrence of Crohn's disease.

Authors:  Shayan Khoshkish; Khalilullah Arefi; Meghedi Charmehali; Homayoon Vahedi; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.